Achilles Therapeutics PLC (NASDAQ:ACHL) is another undervalued small bio cancer play like PHIO with $6 per share in cash and many upcoming catalysts and presentations. Low risk swing from here. Watch the break of the declining EMA50 on volume for a strong rally to the EMA200 that lies at 6.21 I have been accumulating.